TIAA CREF INVESTMENT MANAGEMENT LLC - ARATANA THERAPEUTICS INC ownership

ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 108 filers reported holding ARATANA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 93.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of ARATANA THERAPEUTICS INC
ValueSharesWeighting
Q1 2019$904,000
-43.8%
251,088
-4.3%
0.00%0.0%
Q4 2018$1,608,000
-52.7%
262,345
-55.0%
0.00%0.0%
Q3 2018$3,402,000
+154.5%
582,482
+85.1%
0.00%0.0%
Q2 2018$1,337,000
+107.6%
314,682
+115.6%
0.00%
Q1 2018$644,000
+17.3%
145,960
+39.8%
0.00%
Q4 2017$549,000
-34.6%
104,420
-23.7%
0.00%
-100.0%
Q3 2017$839,000
-48.7%
136,864
-39.6%
0.00%0.0%
Q2 2017$1,637,000
+30.3%
226,464
-4.5%
0.00%0.0%
Q1 2017$1,256,000
-36.4%
237,047
-13.8%
0.00%0.0%
Q4 2016$1,975,000
-38.1%
275,116
-19.3%
0.00%
-50.0%
Q3 2016$3,191,000
+54.8%
340,969
+4.5%
0.00%0.0%
Q2 2016$2,061,000
+167.7%
326,140
+133.7%
0.00%
+100.0%
Q1 2016$770,000
+39.2%
139,549
+40.7%
0.00%
Q4 2015$553,000
-56.8%
99,189
-34.5%
0.00%
-100.0%
Q3 2015$1,280,000
-47.3%
151,342
-5.9%
0.00%
-50.0%
Q2 2015$2,431,000
-5.0%
160,772
+0.6%
0.00%0.0%
Q1 2015$2,559,000
-3.7%
159,829
+7.2%
0.00%0.0%
Q4 2014$2,657,000
+133.1%
149,113
+31.4%
0.00%
+100.0%
Q3 2014$1,140,000
-26.0%
113,505
+15.0%
0.00%0.0%
Q2 2014$1,541,000
+269.5%
98,722
+339.5%
0.00%
Q1 2014$417,000
+30.7%
22,460
+34.6%
0.00%
Q4 2013$319,000
+29.1%
16,692
+10.5%
0.00%
Q3 2013$247,00015,1020.00%
Other shareholders
ARATANA THERAPEUTICS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Engaged Capital LLC 3,487,149$21,376,0003.96%
Broadfin Capital, LLC 4,083,135$25,030,0003.29%
MPM ASSET MANAGEMENT LLC 250,000$1,533,0001.30%
GENERAL AMERICAN INVESTORS CO INC 1,599,365$9,804,0001.03%
Grandeur Peak Global Advisors, LLC 821,038$5,033,0000.65%
CADENCE CAPITAL MANAGEMENT LLC 307,294$1,884,0000.19%
Redmond Asset Management, LLC 60,176$369,0000.18%
Alambic Investment Management, L.P. 65,000$398,0000.17%
MENTA CAPITAL LLC 39,562$243,0000.09%
Campbell & CO Investment Adviser LLC 12,990$88,0000.09%
View complete list of ARATANA THERAPEUTICS INC shareholders